Mesalamine 800 mg delayed-release tablets have been launched, and FDA approval has been granted for lenalidomide, with plans for entry into the U.S. generic market in 2026.
New NIH-AARP study of 471,396 participants shows increased calcium intake from all sources associated with significantly lower colorectal cancer risk over 20+ years of follow-up.
Researchers examined how the 2009 U.S. Preventive Services Task Force mammography guideline update—which recommended biennial screening only for females aged 50 to 74 years—affected screening rates across socioeconomic and geographic subgroups.
Researchers examined systemic absorption, metabolism, and excretion of tattoo ink tracers, providing evidence for a cutaneous first-pass effect and measuring systemic exposure levels.
On January 16, the U.S. Food and Drug Administration (FDA) granted traditional approval to acalabrutinib (Calquence) with bendamustine and rituximab for adults with previously untreated mantle cell ly...
Late relapse of diffuse large B-cell lymphoma (DLBCL) may represent a new lymphoma arising from a common precursor cell that is essentially chemotherapy-naive. Treatment with curative intent using a s...
Scientists have identified a chronic blood-clotting condition characterized by treatment-resistant thrombosis and linked to monoclonal antibodies targeting platelet factor 4, according to a new study.